RUSSIAN CANCER VACCINES
How Russian cancer vaccines EnteroMix and personalized mRNA work to control the life-threatening disease
Russia's cancer vaccine, comprising EnteroMix and personalized mRNA vaccines, has completed preclinical trials, showcasing safety and high efficacy. Research conducted by the NMRRC demonstrated tumor size reduction and slowed progression, ranging from 60% to 80%, alongside increased survival rates. The vaccines aim to destroy malignant cells and activate the patient's antitumor immunity.
A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read
Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially targeting colorectal cancer, has shown significant tumor reduction and improved survival rates. Researchers are also developing versions for glioblastoma and melanoma, potentially revolutionizing cancer treatment.
Russian vaccine for colon cancer ready to use: Report
Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, demonstrating safety and high efficacy. The vaccine, initially targeting colorectal cancer, showed significant reductions in tumor size and improved survival rates. Further advancements are being made in developing vaccines for glioblastoma and melanoma.
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccine
Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innovative vaccine, tailored to individual tumor genetics using AI, aims to stimulate the immune system to target and eradicate cancer cells.
Coming soon: A cancer vaccine for free, courtesy Russia
Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inhibits tumor growth and spread. Researchers are also using AI to personalize cancer vaccines, potentially reducing creation time to under an hour.
- Go To Page 1
Meet Kash Patel, the likely CIA chief under Donald Trump, who has a secret plan to remove 'Govt Gangsters' from the White House
Charles Kupperman expressed concerns about Donald Trump's plan to fill a second administration with loyalists like Kash Patel. Patel gained prominence in the Trump administration and pursued various ventures post-2020 election. His roles included controversial stints in national security and the Pentagon, highlighting his influence and ambitions in line with Trump's agenda.
Superbug crisis: Antibiotic-resistant superbugs may kill 4 crore people worldwide, claims new study
Superbugs: Antimicrobial resistance (AMR) could claim over 39 million lives globally by 2050, warns a study in The Lancet. The report highlights the severe impact of AMR on global health and economies, particularly in South Asia. Immediate action is needed to combat this growing threat through improved healthcare and responsible antibiotic use.
Baba Vanga's 2024 predictions come true: From cancer vaccine to global economic crisis
In 2024, several of Baba Vanga's predictions appear to be coming true, including the development of a cancer vaccine by Russia and the onset of a global economic crisis affecting nations like Japan and the UK. Beyond these, her foresight also extends to increased terrorism, natural disasters, cyber attacks, and even an assassination attempt on Vladimir Putin.
Russian President Vladimir Putin claims significant progress made towards Cancer vaccines
Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing cancer treatment globally. He shared this breakthrough at a Moscow forum on future technologies, expressing hope for their effective use in individual therapy. While Putin did not specify the targeted cancers or mechanisms, various countries and companies, including the UK and BioNTech, are actively working on similar treatments. This development comes amidst Russia's global distribution of the Sputnik V COVID-19 vaccine, with Putin highlighting vaccine safety and efficacy.
Top US lawmakers reach deal on Ukraine aid, $1.5 trillion spending
Though a tiny portion of the massive bill, the money responding to the Russian blitzkrieg that's devastated parts of Ukraine and prompted Europe's worst refugee crisis since World War II ensured robust bipartisan support for the legislation.
Ukraine aid grows to near $14 billion in $1.5 trillion government bill
Republicans accused Biden of moving too slowly to help Ukraine and NATO nations assisting it, and to impose sanctions against Russia and its president, Vladimir Putin. Democrats say time was needed to bring along European allies that rely heavily on Russian energy sources. And a bipartisan push to ban Russian oil imports had grown perhaps unstoppable before Biden announced Tuesday that he would do that on his own.
Text of President Joe Biden's State of the Union address
Madam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Court. My fellow Americans.
Wheels only, please: Iran marks 1979 revolution anniversary
"There is no other way for the world and for the region," Rouhani said during a televised speech. "The only path is definitely the path of diplomacy. The only path is the world's agreement with Iran. God willing, we will be successful in this path."
Donald Trump's legacy: He changed the presidency, but will it last?
Trump, governing by whim and tweet, deepened the nation's racial and cultural divides and undermined faith in its institutions. His legacy: a tumultuous four years that were marked by his impeachment, failures during the worst pandemic in a century and his refusal to accept defeat.
Shot in the dark: Early coronavirus vaccine efficacy explained
The jump to mass vaccinations presents new hurdles, in particular for an mRNA vaccine like Pfizer and BioNTech's that must be stored and shipped at minus 70 degrees Celsius (-94°F).
Shot in the dark: Early COVID-19 vaccine efficacy explained
Typically, regulators strive to have at least 95% certainty that the trial read-out is not the result of random variations with nothing to do with the tested compound. For trial sponsors there is safety in numbers as a large enough trial can ensure that 95% reliability hurdle is cleared.
Russia plans to register the world's first coronavirus vaccine on August 12
"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa.
Global Indian Women: Top 20 India-born & globally successful women from business and arts
An ET Magazine-MavenMagnet study on global women achievers of Indian origin in business and the arts who are creating the biggest buzz online.
Load More
